Events

Participants include Kevin Outterson, Executive Director of CARB-X. The world needs a new generation of antibiotics to address the rapid growth in antibiotic-resistant bacteria. The UK government’s 2014 Review on Antimicrobial Resistance estimated that such bacteria could result in the deaths of 10 million people a year by 2050 and an accumulated cost of up […]

Speakers include Kevin Outterson, Executive Director of CARB-X. The ESCMID Conference on Coronavirus Disease (ECCVID) will take place online from Wednesday 23rd to Friday 25th September 2020 and will cover all aspects of COVID-19. ECCVID will feature a comprehensive scientific programme that will span a wide range of topics surrounding this emerging threat.  COVID-19 is a major […]

AMR in the Light of COVID-19 - A Webinar Series Each of us is now living in a world with a nearly untreatable virus - but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to […]

Speakers: Value of a pre-IND interaction with the US FDA during late lead optimization: Bugworks experience - Bala Subramanian, Bugworks Research Inc. Amicidins: Building clinical and regulatory strategies for non-traditional products to prevent and treat life-threatening infections - Michael P. Bevilacqua, Amicrobe, Inc. Discovery and development of microbiome therapeutics using reverse translation - Matthew Henn […]

CARB-X speakers include Nadia Cohen, Alliance Manager. The World Vaccine Congress is an award-winning series of conferences and an exhibition that has grown to become the largest and most established vaccine meeting of its kind across the globe. Due to the global pandemic, we have made a decision to run the 2020 congress VIRTUALLY. To […]

Recent CARB-X graduate, Specific Diagnostics, will be participating in this workshop. This workshop will be a forum for start-up and SMEs developing diagnostic tests to: Hear from successful entrepreneurs who have built diagnostic companies, what do they think were their key factors for success? Hear from venture capital investors about what they expect and need […]

CARB-X speakers include Su Chiang, Alliance Manager. The 7th BAARN meeting will bring together the leading voices in academia and industry to addresss a defining global health crisis of our age: antibiotic resistant infection. This year will be BAARN's inaugural virtual meeting. We are using online platforms to present an amazing lineup of researchers and innovators, […]

Erin Duffy, CARB-X Chief of R&D, is the chairperson of the event as well as a participant in a number of panels.  Other participants from CARB-X include Kevin Outterson (Executive Director), Richard Alm (Therapeutic R&D Alliance Director), Ed Buurman (Prevention R&D Alliance Director) and Betsy Wonderly Trainor (Diagnostic R&D Alliance Director). The 6th annual World […]

AMR in the Light of COVID-19 - A Webinar Series Each of us is now living in a world with a nearly untreatable virus - but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to […]

The study of the human microbiome remains one of the most exciting frontiers in modern medicine that if targeted correctly, has the potential to benefit millions of patients suffering from numerous diseases. However, the potential for effective medicines powered by the microbiome is matched by the unique challenges in developing them. The Microbiome Movement – […]